National Mammography Database for Breast Cancer Screening and Diagnosis
This study, called the National Mammography Database (NMD), is collecting information from radiology practices that perform mammograms. It's not testing a new drug or treatment, but rather gathering data that these practices already collect to help them compare their results with national and regional averages. The goal is to see how well breast cancer is detected (Cancer Detection Rate) over one year. Anyone between 2 and 99 years old, regardless of gender, can be included in the data collection. There are no specific exclusion criteria. The current status of the study is unclear, but it aims to include data from 8,000,000 individuals.
- Study design
- This is an observational study, meaning it collects existing data rather than testing a specific intervention. It aims to include data from 8,000,000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Cancer detection rates are measured at 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
National Mammography Database
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Cancer Detection Rate1 year
This outcome measure is measured using one year of follow-up after a mammogram is performed on a woman, and is aggregated by interpreting physician. Because the NMD is a registry and screening mammograms are annual exams for most patients, this measure is calculated each year using one year of follow-up.